Novel Peptide-Calix[4]arene novel N No Nov Nove BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 -[] 3 10 1 0 0 0 1
Rescues Neurons rescues R Re Res Resc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ' 1 8 1 0 0 0 1
Grazia Maria grazia G Gr Gra Graz BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 ,*,,,, 6 10 1 0 0 0 1
Giuseppe Di giuseppe G Gi Giu Gius BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 ,,,* 4 8 1 0 0 0 1
Cite This: cite C Ci Cit Cite BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 :..,,- 6 10 1 0 0 0 1
Read Online read R Re Rea Read BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 1 no 0 2 1 0 0 0 1
ACCESS ACCESS access A AC ACC ACCE BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 10 1 0 0 0 1
Metrics & metrics M Me Met Metr BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 1 no 0 6 1 0 0 0 1
Article Recommendations article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 10 1 0 0 0 1
* sı * * * * * BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 1 * 1 10 1 0 0 0 1
ABSTRACT: Alzheimer's abstract: A AB ABS ABST BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 :'(). 5 8 1 0 0 0 1
aggregation of aggregation a ag agg aggr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 -(). 4 9 1 0 0 0 1
based inhibitors based b ba bas base BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 - 1 9 1 0 0 0 1
AD. Peptide ad. A AD AD. AD. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 .. 2 9 1 0 0 0 1
Here we here H He Her Here BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 ,,--[] 6 10 1 0 0 0 1
GPGKLVFF peptide gpgklvff G GP GPG GPGK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 .--[]- 6 8 1 0 0 0 1
Aβ 42 aβ A Aβ Aβ Aβ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 '- 2 9 1 0 0 0 1
the aggregation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 (),(),() 8 9 1 0 0 0 1
measurements, respectively. measurements, m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ,.(-)-- 7 8 1 0 0 0 1
calix[4]arene-GPGKLVFF conjugate calix[4]arene-gpgklvff c ca cal cali BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 1 []-, 4 8 1 0 0 0 1
alteration of alteration a al alt alte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ',-, 4 9 1 0 0 0 1
(AFM) imaging. (afm) ( (A (AF (AFM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 ().,' 5 9 1 0 0 0 1
neuroblastoma cells, neuroblastoma n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 ,-. 3 2 1 0 0 0 1
KEYWORDS: Aβ keywords: K KE KEY KEYW BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 :,,,,- 6 5 1 0 0 0 1
■ INTRODUCTION ■ ■ ■ ■ ■ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 7 no 0 10 1 0 0 0 1
Alzheimer's disease alzheimer's A Al Alz Alzh BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 7 '() 3 9 1 0 0 0 1
neurodegenerative condition neurodegenerative n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 no 0 9 1 0 0 0 1
affects older affects a af aff affe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ." 2 8 1 0 0 0 1
misfolding diseases" misfolding m mi mis misf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 " 1 9 1 0 0 0 1
and still and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 9 1 0 0 0 1
for scientific for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 9 1 0 0 0 1
fields. The fields. f fi fie fiel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 . 1 9 1 0 0 0 1
fully elucidated, fully f fu ful full BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ,,, 3 10 1 0 0 0 1
form of form f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 (),- 4 8 1 0 0 0 1
mental risk mental m me men ment BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 , 1 9 1 0 0 0 1
clarified. 2 clarified. c cl cla clar BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 .,, 3 10 1 0 0 0 1
the market, the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 , 1 9 1 0 0 0 1
can slow can c ca can can BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 . 1 8 1 0 0 0 1
pathological hallmarks pathological p pa pat path BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 no 0 9 1 0 0 0 1
Received: March received: R Re Rec Rece BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 :, 2 9 1 0 0 0 1
Accepted: March accepted: A Ac Acc Acce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 :, 2 9 1 0 0 0 1
Published: April published: P Pu Pub Publ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 :, 2 10 1 0 0 0 1
Research Article research R Re Res Rese BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 11 no 0 7 1 1 0 0 1
pubs.acs.org/chemneuro pubs.acs.org/chemneuro pubs.acs.org/chemneuro p pu pub pubs BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 11 ../ 3 10 1 1 0 0 1
© 2021 © © © © © BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 11 no 0 10 1 1 0 0 0
1449 1449 1449 1 14 144 1449 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 0 11 no 0 10 1 1 0 0 0
https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 0 11 ://././. 8 10 1 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 0 11 ..,,- 5 8 1 1 0 0 0
plaques mainly plaques p pl pla plaq BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 8 0 0 0 0 1
(Aβ) peptide, (aβ) ( (A (Aβ (Aβ) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (),- 4 8 0 0 0 0 1
amyloid precursor amyloid a am amy amyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (). 3 8 0 0 0 0 1
that early that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
protofibrils are protofibrils p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
system compared system s sy sys syst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ., 2 8 0 0 0 0 1
about the about a ab abo abou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
difficult to difficult d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 8 0 0 0 0 1
heterogeneous properties heterogeneous h he het hete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
challenges for challenges c ch cha chal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 7 0 0 0 0 1
mechanisms. Some mechanisms. m me mec mech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 8 0 0 0 0 1
toxic function toxic t to tox toxi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
neurons with neurons n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ., 2 8 0 0 0 0 1
Thus, unveiling thus, T Th Thu Thus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 9 0 0 0 0 1
is turning is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
design of design d de des desi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
species. 9,10 species. s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .,- 3 9 0 0 0 0 1
the characteristic the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -. 2 9 0 0 0 0 1
aggregation is aggregation a ag agg aggr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 , 1 9 0 0 0 0 1
an exclusively an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 . 1 9 0 0 0 0 1
Aβ's fibrillogenesis aβ's A Aβ Aβ' Aβ's BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ' 1 9 0 0 0 0 1
function of function f fu fun func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
production of production p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 , 1 8 0 0 0 0 1
role has role r ro rol role BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ., 2 8 0 0 0 0 1
metal chelators, metal m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,-, 3 8 0 0 0 0 1
short peptides short s sh sho shor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
aggregation. 13-16 aggregation. a ag agg aggr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 .-, 3 8 0 0 0 0 1
abnormal metal abnormal a ab abn abno BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
studies aimed studies s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
using metal using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
aberrant metal aberrant a ab abe aber BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
metal induced metal m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .- 2 9 0 0 0 0 1
hydrophobic core hydrophobic h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 -() 3 8 0 0 0 0 1
for the for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 8 0 0 0 0 1
investigation of investigation i in inv inve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
fibrillogenesis. 21 fibrillogenesis. f fi fib fibr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 . 1 8 0 0 0 0 1
KLVFF peptide, klvff K KL KLV KLVF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,- 2 8 0 0 0 0 1
length Aβ, length l le len leng BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,,, 3 10 0 0 0 0 1
ability is ability a ab abi abil BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
including oligolysines, including i in inc incl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,,, 3 9 0 0 0 0 1
porphyrins. 27,28 porphyrins. p po por porp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ., 2 2 0 0 0 0 1
Therefore, conjugation therefore, T Th The Ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 0 0 0 0 1
to modify to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 7 0 0 0 0 1
candidate. 29,30 candidate. c ca can cand BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ., 2 8 0 0 0 0 1
cytotoxic payload cytotoxic c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
targeted by targeted t ta tar targ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .[] 3 8 0 0 0 0 1
polyphenols proposed polyphenols p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
of application. of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 8 0 0 0 0 1
structure and structure s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
in supramolecular in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 .[-] 4 8 0 0 0 0 1
possess a possess p po pos poss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
and can and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 0 0 0 0 1
providing rigid providing p pr pro prov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
recognition events. recognition r re rec reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 8 0 0 0 0 1
exhibited by exhibited e ex exh exhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 [] 2 8 0 0 0 0 1
advanced these advanced a ad adv adva BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
and pharmaceutical and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .[] 3 8 0 0 0 0 1
been proposed been b be bee been BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,, 2 8 0 0 0 0 1
vaccines, 36 vaccines, v va vac vacc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,, 2 9 0 0 0 0 1
systems. Opportunely systems. s sy sys syst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .,[] 4 8 0 0 0 0 1
also been also a al als also BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
relevant biological relevant r re rel rele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 9 0 0 0 0 1
protein-carbohydrate interactions. protein-carbohydrate p pr pro prot BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -.,[] 5 9 0 0 0 0 1
been successfully been b be bee been BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 8 0 0 0 0 1
detection 40 detection d de det dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ., 2 9 0 0 0 0 1
wide use wide w wi wid wide BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 [], 3 10 0 0 0 0 1
few papers few f fe few few BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 [] 2 9 0 0 0 0 1
derivatives with derivatives d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ..-- 4 8 0 0 0 0 1
calix[4,6,8]arenes with calix[4,6,8]arenes c ca cal cali BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 [,,]- 5 8 0 0 0 0 1
Aβ 42 aβ A Aβ Aβ Aβ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 . 1 9 0 0 0 0 1
al. synthesized al. a al al. al. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 . 1 9 0 0 0 0 1
p-sulfonate calix[4]arene p-sulfonate p p- p-s p-su BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 -[]-, 5 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 8 0 0 0 0 1
assembly surface assembly a as ass asse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 9 0 0 0 0 1
inducing fibril inducing i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 9 0 0 0 0 1
the calixarene the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 0 0 0 0 1
generate a generate g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ., 2 9 0 0 0 0 1
the design the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 []- 3 8 0 0 0 0 1
conjugate composed conjugate c co con conj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 --[] 4 8 0 0 0 0 1
bearing a bearing b be bea bear BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 8 0 0 0 0 1
lower rim. lower l lo low lowe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 8 0 0 0 0 1
characterization of characterization c ch cha char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 9 0 0 0 0 1
to hamper to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 8 0 0 0 0 1
carried out carried c ca car carr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 8 0 0 0 0 1
including circular including i in inc incl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (),() 5 8 0 0 0 0 1
fluorescence, dynamic fluorescence, f fl flu fluo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 ,(), 4 8 0 0 0 0 1
force microscopy force f fo for forc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (). 3 8 0 0 0 0 1
spectrometry (HR-MS) spectrometry s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 (-) 3 8 0 0 0 0 1
interaction of interaction i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 5 --[]-- 6 8 0 0 0 0 1
gate with gate g ga gat gate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 9 0 0 0 0 1
experimental evidence experimental e ex exp expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 0 0 0 0 1
prevent the prevent p pr pre prev BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 9 0 0 0 0 1
SY5Y neuronal sy5y S SY SY5 SY5Y BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 .- 2 8 0 0 0 0 1
peptide conjugate peptide p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 no 0 9 0 0 0 0 1
allows its allows a al all allo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 8 0 0 0 0 1
■ RESULTS ■ ■ ■ ■ ■ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
Design and design D De Des Desi BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 9 []- 3 7 0 0 0 0 1
(5). In (5). ( (5 (5) (5). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 ().[] 5 9 0 0 0 0 1
amyloid fibrillogenesis, amyloid a am amy amyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 , 1 8 0 0 0 0 1
recognition peptide recognition r re rec reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 - 1 8 0 0 0 0 1
soluble p-amino-calix[4]arene soluble s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 --[] 4 9 0 0 0 0 1
hybrid construct hybrid h hy hyb hybr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 no 0 9 0 0 0 0 1
and therefore and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 '- 2 9 0 0 0 0 1
oligomeric/fibrillary toxic oligomeric/fibrillary o ol oli olig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 /. 2 9 0 0 0 0 1
sequence because sequence s se seq sequ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 no 0 9 0 0 0 0 1
to recognize to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 - 1 9 0 0 0 0 1
Aβ peptide. aβ A Aβ Aβ Aβ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 . 1 8 0 0 0 0 1
reduce any reduce r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 - 1 8 0 0 0 0 1
calix-peptide conjugate. calix-peptide c ca cal cali BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 -.--[] 6 9 0 0 0 0 1
should confer should s sh sho shou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 - 1 9 0 0 0 0 1
peptide conjugate, peptide p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 , 1 8 0 0 0 0 1
noncovalent contacts noncovalent n no non nonc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 no 0 9 0 0 0 0 1
residues of residues r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 ., 2 9 0 0 0 0 1
calix-peptide conjugate calix-peptide c ca cal cali BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 - 1 8 0 0 0 0 1
between adjacent between b be bet betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 ' 1 9 0 0 0 0 1
self-assembly process. self-assembly s se sel self BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 -.- 3 9 0 0 0 0 1
systems, the systems, s sy sys syst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 ,- 2 8 0 0 0 0 1
offer some offer o of off offe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 no 0 8 0 0 0 0 1
properties of properties p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 , 1 8 0 0 0 0 1
antiamyloidogenic action antiamyloidogenic a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 - 1 8 0 0 0 0 1
KLVFF as klvff K KL KLV KLVF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 "". 3 9 0 0 0 0 1
moiety might moiety m mo moi moie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
Aβ monomer aβ A Aβ Aβ Aβ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 no 0 9 0 0 0 0 1
oligomeric insult. oligomeric o ol oli olig BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 .- 2 9 0 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 1 11 no 0 10 0 1 0 0 0
pubs.acs.org/chemneuro pubs.acs.org/chemneuro pubs.acs.org/chemneuro p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 11 ../ 3 10 0 1 0 0 0
Research Article research R Re Res Rese BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 11 no 0 7 0 1 0 0 0
https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 1 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 1 11 ..,,- 5 8 0 1 0 0 0
1450 1450 1450 1 14 145 1450 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 1 11 no 0 10 0 1 0 0 0
principle be principle p pr pri prin BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 1 0 0 0 1
compounds or compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 9 1 0 0 0 1
The procedure the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 8 1 0 0 0 1
conjugate (5) conjugate c co con conj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 () 2 9 1 0 0 0 1
Scheme 1. scheme S Sc Sch Sche BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 ., 2 9 1 0 0 0 1
starting material starting s st sta star BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ---[] 5 10 1 0 0 0 1
cone conformation cone c co con cone BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 0 - 1 10 1 0 0 0 1
with three with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 9 1 0 0 0 1
groups were groups g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 [], 3 9 1 0 0 0 1
ipso-nitration followed ipso-nitration i ip ips ipso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 -/ 2 9 1 0 0 0 1
nitro groups. nitro n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 . 1 9 1 0 0 0 1
fragment, the fragment, f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 10 1 0 0 0 1
tert-butyloxycarbonyl (Boc) tert-butyloxycarbonyl t te ter tert BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 -(). 4 8 1 0 0 0 1
Hydrolysis reaction hydrolysis H Hy Hyd Hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 8 1 0 0 0 1
COOH group cooh C CO COO COOH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 1 0 0 0 1
the GPGK(Dde)LVFF the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ()(:-(- 7 8 1 0 0 0 1
(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl). The (4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl). ( (4 (4, (4,4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 (,--,-)).- 10 9 1 0 0 0 1
(Dde)LVFF sequence (dde)lvff ( (D (Dd (Dde BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 () 2 9 1 0 0 0 1
microwave assisted microwave m mi mic micr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (-) 3 9 1 0 0 0 1
reported in reported r re rep repo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ,-- 3 9 1 0 0 0 1
(see Figure (see ( (s (se (see BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 (). 3 9 1 0 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 [] 2 9 1 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 5 . 1 9 1 0 0 0 1
removal of removal r re rem remo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 9 1 0 0 0 1
treatment with treatment t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 10 1 0 0 0 1
gave the gave g ga gav gave BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 1 0 0 0 1
by combined by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 --,--/ 6 7 1 0 0 0 1
NMR spectra nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 (-). 4 8 1 0 0 0 1
Calix[4]arene-GPGKLVFF (5)/Aβ calix[4]arene-gpgklvff C Ca Cal Cali BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 []-()/. 7 7 1 0 0 0 1
assess the assess a as ass asse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 1 0 0 0 1
formation, we formation, f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 7 1 0 0 0 1
fluorescence study. fluorescence f fl flu fluo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 . 1 8 1 0 0 0 1
determination of determination d de det dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 8 1 0 0 0 1
aggregates, respectively. aggregates, a ag agg aggr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ,. 2 4 1 0 0 0 1
CD Spectroscopy. cd C CD CD CD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 . 1 8 1 0 0 0 1
random coil random r ra ran rand BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 9 1 0 0 0 1
Scheme 1. scheme S Sc Sch Sche BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 10 .--[]-() 8 10 1 1 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 1 11 no 0 10 1 1 0 0 0
pubs.acs.org/chemneuro pubs.acs.org/chemneuro pubs.acs.org/chemneuro p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 11 ../ 3 10 1 1 0 0 0
Research Article research R Re Res Rese BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 11 no 0 7 1 1 0 0 0
https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 1 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 1 11 ..,,- 5 8 0 1 0 0 0
1451 1451 1451 1 14 145 1451 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 1 11 no 0 10 0 1 0 0 0
fibrillogenesis of fibrillogenesis f fi fib fibr BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 . 1 10 1 1 0 0 1
experiments, either experiments, e ex exp expe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 9 1 1 0 0 1
coincubated with coincubated c co coi coin BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 2 ( 1 9 1 1 0 0 1
mM, pH mm, m mM mM, mM, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 ,.), 4 10 1 1 0 0 1
Figure 1. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 .(),()/(:),()/(:). 18 10 1 1 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 2 8 no 0 10 1 1 0 0 0
pubs.acs.org/chemneuro pubs.acs.org/chemneuro pubs.acs.org/chemneuro p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 9 ../ 3 10 1 1 0 0 0
Research Article research R Re Res Rese BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 9 no 0 7 1 1 0 0 0
https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 2 9 ://././. 8 10 1 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 2 9 ..,,- 5 8 1 1 0 0 0
1452 1452 1452 1 14 145 1452 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 11 no 0 10 1 1 0 0 0
derivatives on derivatives d de der deri BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 '-. 3 9 1 0 0 0 1
Figure 1 figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 1 0 0 0 1
the presence the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ., 2 9 1 0 0 0 1
the absence the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,() 3 8 1 0 0 0 1
almost complete almost a al alm almo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -. 2 9 1 0 0 0 1
In fact, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 0 , 1 10 1 0 0 0 1
dichroism below dichroism d di dic dich BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 8 1 0 0 0 1
peptide chain. peptide p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 . 1 9 1 0 0 0 1
β-sheet pattern, β-sheet β β- β-s β-sh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 -,. 3 8 1 0 0 0 1
spectrum recorded spectrum s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 1 0 0 0 1
ellipticity at ellipticity e el ell elli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 , 1 9 1 0 0 0 1
thereby indicating thereby t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -. 2 9 1 0 0 0 1
This pattern this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 8 1 0 0 0 1
indicating that indicating i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 1 0 0 0 1
of incubation. of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ., 2 9 1 0 0 0 1
either at either e ei eit eith BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 8 1 0 0 0 1
characteristic β-sheet characteristic c ch cha char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -., 3 9 1 0 0 0 1
CD spectra cd C CD CD CD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 - 1 8 1 0 0 0 1
strong negative strong s st str stro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 0 no 0 9 1 0 0 0 1
inflection of inflection i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 7 1 0 0 0 1
considered interval considered c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 8 1 0 0 0 1
were subjected were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 1 0 0 0 1
and CDSSTR and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ., 2 7 1 0 0 0 1
representation of representation r re rep repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 1 0 0 0 1
conformation as conformation c co con conf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 . 1 9 1 0 0 0 1
The values the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 1 0 0 0 1
are reported are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 9 1 0 0 0 1
higher percentage higher h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 1 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 0 . 1 10 1 0 0 0 1
The CD the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 8 1 0 0 0 1
recorded in recorded r re rec reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 8 1 0 0 0 1
are characterized are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 1 0 0 0 1
not change not n no not not BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (). 3 9 1 0 0 0 1
5 significantly 5 5 5 5 5 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 5 '- 2 8 1 0 0 0 1
transition typically transition t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 . 1 10 1 0 0 0 1
In other in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 5 , 1 9 1 0 0 0 1
Aβ randomly aβ A Aβ Aβ Aβ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 no 0 7 1 0 0 0 1
potentially toxic potentially p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 . 1 8 1 0 0 0 1
ability of ability a ab abi abil BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 [] 2 8 1 0 0 0 1
random coil/β-sheet random r ra ran rand BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 /-. 3 8 1 0 0 0 1
then acquired then t th the then BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 , 1 8 1 0 0 0 1
experimental conditions experimental e ex exp expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 , 1 9 1 0 0 0 1
p-amino-calix[4]arene derivative p-amino-calix[4]arene p p- p-a p-am BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 --[]:: 6 8 1 0 0 0 1
ratios. CD ratios. r ra rat rati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 . 1 8 1 0 0 0 1
with Aβ with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 (),. 4 9 1 0 0 0 1
also became also a al als also BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ( 1 8 1 0 0 0 1
2) where 2) 2 2) 2) 2) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 ) 1 8 1 0 0 0 1
than the than t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 . 1 9 1 0 0 0 1
effect of effect e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 '- 2 8 1 0 0 0 1
process was process p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ., 2 8 1 0 0 0 1
CD data cd C CD CD CD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 no 0 9 1 0 0 0 1
with the with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ()., 4 7 1 0 0 0 1
comparison with comparison c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 no 0 8 1 0 0 0 1
conjugate 5 conjugate c co con conj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 . 1 9 1 0 0 0 1
case of case c ca cas case BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 5 ,:, 3 9 1 0 0 0 1
GPGKLVFF peptide gpgklvff G GP GPG GPGK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 no 0 8 1 0 0 0 1
process. This process. p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 .( 2 8 1 0 0 0 1
S13). A s13). S S1 S13 S13) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 ).- 3 8 1 0 0 0 1
observed after observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ( 1 8 1 0 0 0 1
conformation after conformation c co con conf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 ). 2 8 1 0 0 0 1
rate caused rate r ra rat rate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 , 1 8 1 0 0 0 1
acquire CD acquire a ac acq acqu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 (). 3 7 1 0 0 0 1
obtained at obtained o ob obt obta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 : 1 8 1 0 0 0 1
slow down slow s sl slo slow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ,, 2 9 1 0 0 0 1
lesser extent lesser l le les less BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 no 0 8 1 0 0 0 1
calix-peptide conjugate calix-peptide c ca cal cali BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 -::. 4 7 1 0 0 0 1
Figure 2. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 10 . 1 10 1 0 0 0 1
deconvolution algorithms. deconvolution d de dec deco BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 10 .;.*. 5 9 1 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 2 11 no 0 10 1 1 0 0 0
pubs.acs.org/chemneuro pubs.acs.org/chemneuro pubs.acs.org/chemneuro p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 ../ 3 10 1 1 0 0 0
Research Article research R Re Res Rese BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 11 no 0 7 1 1 0 0 0
https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 2 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 2 11 ..,,- 5 8 0 1 0 0 0
1453 1453 1453 1 14 145 1453 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 11 no 0 10 0 1 0 0 0
conclusion, the conclusion, c co con conc BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 9 1 0 0 0 1
GPGKLVFF can gpgklvff G GP GPG GPGK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 - 1 9 1 0 0 0 1
conformation. Importantly, conformation. c co con conf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ., 2 8 1 0 0 0 1
indicated the indicated i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 10 1 0 0 0 1
Aβ 42 aβ A Aβ Aβ Aβ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 9 1 0 0 0 1
moieties. moieties. moieties. m mo moi moie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 . 1 1 1 0 0 0 1
Thioflavin T thioflavin T Th Thi Thio BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 (). 3 9 1 0 0 0 1
aggregation was aggregation a ag agg aggr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 . 1 9 1 0 0 0 1
fluorophore that fluorophore f fl flu fluo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 9 1 0 0 0 1
binding to binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 9 1 0 0 0 1
monitored at monitored m mo mon moni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 9 1 0 0 0 1
presented in presented p pr pre pres BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ., 2 9 1 0 0 0 1
displayed a displayed d di dis disp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 , 1 9 1 0 0 0 1
from the from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 8 1 0 0 0 1
peptide. It peptide. p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 . 1 8 1 0 0 0 1
displays just displays d di dis disp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 (,). 4 10 1 0 0 0 1
The prompt the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 () 2 8 1 0 0 0 1
the responsible the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 . 1 9 1 0 0 0 1
fluorescence intensity fluorescence f fl flu fluo BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 no 0 8 1 0 0 0 1
inhibitors at inhibitors i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 - 1 9 1 0 0 0 1
related to related r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 . 1 9 1 0 0 0 1
The antifibrillogenic the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 8 1 0 0 0 1
evident at evident e ev evi evid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 (,). 4 9 1 0 0 0 1
observed profile observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 (), 3 9 1 0 0 0 1
that suggests that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 8 1 0 0 0 1
events of events e ev eve even BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 2 . 1 4 1 0 0 0 1
Such an such S Su Suc Such BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 - 1 8 1 0 0 0 1
excess. As excess. e ex exc exce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 .,, 3 8 1 0 0 0 1
negligible increasing negligible n ne neg negl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 , 1 9 1 0 0 0 1
almost complete almost a al alm almo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 (, 2 9 1 0 0 0 1
blue). The blue). b bl blu blue BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 ). 2 9 1 0 0 0 1
precursor 1 precursor p pr pre prec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 8 1 0 0 0 1
capability of capability c ca cap capa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 8 1 0 0 0 1
fibrillogenic process, fibrillogenic f fi fib fibr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 , 1 8 1 0 0 0 1
compound 5. compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 . 1 7 1 0 0 0 1
fluorescence intensity fluorescence f fl flu fluo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 ,,, 3 10 1 0 0 0 1
was not was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 . 1 8 1 0 0 0 1
observed at observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 :. 2 8 1 0 0 0 1
activated Aβ activated a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 (,). 4 8 1 0 0 0 1
proaggregating behavior proaggregating p pr pro proa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 - 1 8 1 0 0 0 1
ments, and ments, m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 ,. 2 8 1 0 0 0 1
sample reaches sample s sa sam samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 2 no 0 8 1 0 0 0 1
Aβ 42 aβ A Aβ Aβ Aβ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 2 . 1 8 1 0 0 0 1
somehow self-aggregate somehow s so som some BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 -, 2 8 1 0 0 0 1
ThT experiments tht T Th ThT ThT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 2 no 0 8 1 0 0 0 1
between ThT between b be bet betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 ,( 2 7 1 0 0 0 1
S14). An s14). S S1 S14 S14) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 ). 2 9 1 0 0 0 1
GPGKLVFF compound gpgklvff G GP GPG GPGK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 2 no 0 7 1 0 0 0 1
positive heterofibrils positive p po pos posi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 (,). 4 9 1 0 0 0 1
the ThT the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 8 1 0 0 0 1
dose responsive dose d do dos dose BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 . 1 8 1 0 0 0 1
analysis of analysis a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 8 1 0 0 0 1
fitting using fitting f fi fit fitt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 , 1 8 1 0 0 0 1
parameters are parameters p pa par para BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 ( 1 8 1 0 0 0 1
S2). S2). s2). S S2 S2) S2). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 ). 2 0 1 0 0 0 1
Dynamic Light dynamic D Dy Dyn Dyna BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 (). 3 7 1 0 0 0 1
measurements to measurements m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 8 1 0 0 0 1
in solution in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 2 , 1 9 1 0 0 0 1
absence or absence a ab abs abse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 . 1 9 1 0 0 0 1
and 120 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 8 1 0 0 0 1
number of number n nu num numb BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 . 1 8 1 0 0 0 1
Figure 3. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 . 1 9 1 0 0 0 1
assays of assays a as ass assa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 (,)- 4 9 1 0 0 0 1
fold molar fold f fo fol fold BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 ,(/:, 5 9 1 0 0 0 1
blue), (Aβ blue), b bl blu blue BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 9 ),(/:,),(/:,),(/,: 18 10 1 0 0 0 1
blue), (Aβ blue), b bl blu blue BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 9 ),(/:,),(/:,). 14 9 1 0 0 0 1
*The extraction *the * *T *Th *The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 9 * 1 9 1 0 0 0 1
equation in equation e eq equ equa BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 . 1 7 1 0 0 0 1
Figure 4. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 .()()(/:) 9 10 1 1 0 0 1
incubation at incubation i in inc incu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 . 1 3 1 1 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 0
pubs.acs.org/chemneuro pubs.acs.org/chemneuro pubs.acs.org/chemneuro p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 11 ../ 3 10 0 1 0 0 0
Research Article research R Re Res Rese BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 11 no 0 7 0 1 0 0 0
https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 3 11 ://././. 8 10 1 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 3 11 ..,,- 5 8 1 1 0 0 0
1454 1454 1454 1 14 145 1454 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 3 11 no 0 10 1 1 0 0 0
small aggregates small s sm sma smal BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 0 no 0 9 1 0 0 0 1
scattering objects scattering s sc sca scat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (). 3 9 1 0 0 0 1
The end the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 1 0 0 0 1
the formation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ., 2 9 1 0 0 0 1
the DLS the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 1 0 0 0 1
increased diameter increased i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 () 2 8 1 0 0 0 1
scattering entities, scattering s sc sca scat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 1 0 0 0 1
aggregates with aggregates a ag agg aggr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 8 1 0 0 0 1
collected in collected c co col coll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 10 1 0 0 0 1
the dimension the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 1 0 0 0 1
end point end e en end end BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 .,, 3 9 1 0 0 0 1
scattering particles scattering s sc sca scat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 1 0 0 0 1
around 45 around a ar aro arou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (), 3 9 1 0 0 0 1
84 nm 84 8 84 84 84 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 0 . 1 8 1 0 0 0 1
compound 5 compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 () 2 8 1 0 0 0 1
mean hydrodynamic mean m me mea mean BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 8 1 0 0 0 1
aggregates (diameter aggregates a ag agg aggr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ()( 3 9 1 0 0 0 1
S15). At s15). S S1 S15 S15) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 )., 3 8 1 0 0 0 1
mean hydrodynamic mean m me mea mean BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 1 0 0 0 1
mV (Figure mv m mV mV mV BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 (). 3 2 1 0 0 0 1
AFM Analysis. afm A AF AFM AFM BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 4 .() 3 7 1 0 0 0 1
revealed the revealed r re rev reve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 . 1 9 1 0 0 0 1
that, after that, t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 ,,() 4 9 1 0 0 0 1
fibrillary network fibrillary f fi fib fibr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 .. 2 9 1 0 0 0 1
nm. The nm. n nm nm. nm. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 .,(), 5 8 1 0 0 0 1
during the during d du dur duri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 , 1 9 1 0 0 0 1
development of development d de dev deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 4 , 1 8 1 0 0 0 1
aggregates are aggregates a ag agg aggr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 ..( 3 9 1 0 0 0 1
5b). Statistical 5b). 5 5b 5b) 5b). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 4 ). 2 10 1 0 0 0 1
reported in reported r re rep repo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 ,. 2 8 1 0 0 0 1
further confirmed further f fu fur furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 8 1 0 0 0 1
formation in formation f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 . 1 8 1 0 0 0 1
MS Study ms M MS MS MS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 4 //.- 4 8 1 0 0 0 1
MS measurements ms M MS MS MS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 4 no 0 9 1 0 0 0 1
molecular adducts molecular m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 7 1 0 0 0 1
conjugate 5 conjugate c co con conj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 . 1 8 1 0 0 0 1
Aβ 42 aβ A Aβ Aβ Aβ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 4 :// 3 8 1 0 0 0 1
GPGKLVFF, were gpgklvff, G GP GPG GPGK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 4 , 1 8 1 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 4 . 1 8 1 0 0 0 1
lyophilized sample lyophilized l ly lyo lyop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 no 0 8 1 0 0 0 1
(HFIP) and (hfip) ( (H (HF (HFI BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 4 (), 3 8 1 0 0 0 1
Figure 5. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 .()()()().() 12 10 1 0 0 0 1
Aβ 42 aβ A Aβ Aβ Aβ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 ()()(). 7 3 1 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 3 11 no 0 10 1 1 0 0 0
pubs.acs.org/chemneuro pubs.acs.org/chemneuro pubs.acs.org/chemneuro p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 11 ../ 3 10 1 1 0 0 0
Research Article research R Re Res Rese BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 11 no 0 7 1 1 0 0 0
https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 3 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 3 11 ..,,- 5 8 0 1 0 0 0
1455 1455 1455 1 14 145 1455 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 3 11 no 0 10 0 1 0 0 0
concentration of concentration c co con conc BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 .-().- 6 7 1 0 0 0 1
spectrum of spectrum s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 / 1 8 1 0 0 0 1
1129.33 and 1129.33 1 11 112 1129 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 3 0 ..[][], 7 10 1 0 0 0 1
respectively. A respectively. r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 .- 2 8 1 0 0 0 1
revealed a revealed r re rev reve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 /. 2 9 1 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (,). 4 9 1 0 0 0 1
This signal this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 1 0 0 0 1
Aβ 42 aβ A Aβ Aβ Aβ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 /(),/. 6 9 1 0 0 0 1
2010.06 corresponding 2010.06 2 20 201 2010 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 3 0 ./ 2 9 1 0 0 0 1
5 adduct 5 5 5 5 5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 0 . 1 9 1 0 0 0 1
spectrum of spectrum s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 /()., 5 8 1 0 0 0 1
m/z signals m/z m m/ m/z m/z BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 /..[/ 5 9 1 0 0 0 1
GPGKLVFF] 4+ gpgklvff] G GP GPG GPGK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 ][/],- 6 8 1 0 0 0 1
tively, with tively, t ti tiv tive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ,. 2 9 1 0 0 0 1
Despite the despite D De Des Desp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 1 0 0 0 1
the gas-phase the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -, 2 9 1 0 0 0 1
solution in solution s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 1 0 0 0 1
GPGKLVFF or gpgklvff G GP GPG GPGK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 ., 2 8 1 0 0 0 1
dimeric form dimeric d di dim dime BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 8 1 0 0 0 1
spectrum when spectrum s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 7 1 0 0 0 1
sample solution. sample s sa sam samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 0 .,, 3 9 1 0 0 0 1
interactions occur interactions i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 1 0 0 0 1
the early the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 1 0 0 0 1
our previous our o ou our our BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,, 2 8 1 0 0 0 1
resistant peptides resistant r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 1 0 0 0 1
the binding the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ., 2 8 1 0 0 0 1
cleavage of cleavage c cl cle clea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 9 1 0 0 0 1
accessible unstructured accessible a ac acc acce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 1 0 0 0 1
steric hindrance steric s st ste ster BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 9 1 0 0 0 1
affect the affect a af aff affe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 1 0 0 0 1
fragments generated fragments f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 1 0 0 0 1
selectively catalyzes selectively s se sel sele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 9 1 0 0 0 1
terminal side terminal t te ter term BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ., 2 9 1 0 0 0 1
the peptide the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (-),(-),(-) 11 8 1 0 0 0 1
were detected were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -(), 4 8 1 0 0 0 1
indicating the indicating i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,, 2 9 1 0 0 0 1
28 of 28 2 28 28 28 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 0 .(-) 4 7 1 0 0 0 1
observed. It observed. o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 1 0 0 0 1
of Aβ of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 --- 3 10 1 0 0 0 1
site (Scheme site s si sit site BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (). 3 8 1 0 0 0 1
Aβ 42 aβ A Aβ Aβ Aβ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 9 1 0 0 0 1
accomplished after accomplished a ac acc acco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ()., 4 9 1 0 0 0 1
fragments Aβ(17-42), fragments f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (-),(-),, 9 8 1 0 0 0 1
imputable to imputable i im imp impu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 , 1 8 1 0 0 0 1
the mass the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (,) 3 8 1 0 0 0 1
after 2 after a af aft afte BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 1 0 0 0 1
results were results r re res resu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 8 / 1 9 1 1 0 0 1
mixture (data mixture m mi mix mixt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 (). 3 10 1 1 0 0 1
GPGKLVFF and gpgklvff G GP GPG GPGK BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 no 0 9 1 1 0 0 1
Figure 6. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 9 .-. 3 10 1 0 0 0 1
of peak of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 9 . 1 4 1 0 0 0 1
Figure 7. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 9 .() 3 9 1 0 0 0 1
and (b) and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 9 ()/.() 6 10 1 0 0 0 1
of Aβ of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 9 (). 3 10 1 0 0 0 1
Figure 8. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 10 .-/() 5 9 1 0 0 0 1
Aβ 42 aβ A Aβ Aβ Aβ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 10 ()/ 3 10 1 0 0 0 1
with trypsin. with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 .()(-)(-) 9 9 1 0 0 0 1
both in both b bo bot both BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 . 1 7 1 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 4 11 no 0 10 1 1 0 0 0
pubs.acs.org/chemneuro pubs.acs.org/chemneuro pubs.acs.org/chemneuro p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 11 ../ 3 10 1 1 0 0 0
Research Article research R Re Res Rese BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 4 11 no 0 7 1 1 0 0 0
https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 4 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 4 11 ..,,- 5 8 0 1 0 0 0
1456 1456 1456 1 14 145 1456 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 4 11 no 0 10 0 1 0 0 0
indicating that indicating i in ind indi BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 '. 2 10 1 0 0 0 1
Therefore, it therefore, T Th The Ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 8 1 0 0 0 1
GPGKLVFF or gpgklvff G GP GPG GPGK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 8 1 0 0 0 1
amyloid protein amyloid a am amy amyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 . 1 9 1 0 0 0 1
fragments were fragments f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 9 1 0 0 0 1
and proteins and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 1 0 0 0 1
the generation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 1 0 0 0 1
electrochemical process. electrochemical e el ele elec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 . 1 4 1 0 0 0 1
Cytotoxicity Studies. cytotoxicity C Cy Cyt Cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 . 1 8 1 0 0 0 1
results, we results, r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 9 1 0 0 0 1
activity in activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 () 2 9 1 0 0 0 1
neuronal cells neuronal n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 () 2 10 1 0 0 0 1
prevent oligomers prevent p pr pre prev BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ., 2 8 1 0 0 0 1
neuroblastoma cell neuroblastoma n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ,-,- 4 9 1 0 0 0 1
ing to ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 4 0 -( 2 8 1 0 0 0 1
Section). After section). S Se Sec Sect BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 ).-- 4 9 1 0 0 0 1
acid (RA) acid a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 () 2 7 1 0 0 0 1
phenotype, we phenotype, p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 9 1 0 0 0 1
compound 5 compound c co com comp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (.,,,)(). 9 8 1 0 0 0 1
peptides KLVFF peptides p pe pep pept BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 2 . 1 8 1 0 0 0 1
As expected, as A As As As BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 2 , 1 8 1 0 0 0 1
containing the containing c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 () 2 7 1 0 0 0 1
revealed similar revealed r re rev reve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 ., 2 9 1 0 0 0 1
toxicity was toxicity t to tox toxi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 no 0 7 1 0 0 0 1
concentrations used, concentrations c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 ,, 2 9 1 0 0 0 1
significant, trend significant, s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 ,(.-) 5 8 1 0 0 0 1
response, after response, r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 ,., 3 9 1 0 0 0 1
compound 5 compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 no 0 7 1 0 0 0 1
cytotoxic insult. cytotoxic c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 2 .() 3 8 1 0 0 0 1
freshly prepared freshly f fr fre fres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 , 1 9 1 0 0 0 1
the presence the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 - 1 8 1 0 0 0 1
conjugate 5. conjugate c co con conj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 . 1 1 1 0 0 0 1
Aβ oligomers aβ A Aβ Aβ Aβ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 2 no 0 8 1 0 0 0 1
at the at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 , 1 8 1 0 0 0 1
with all with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 ::. 3 8 1 0 0 0 1
Cells, were cells, C Ce Cel Cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 2 , 1 8 1 0 0 0 1
and cell and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 . 1 8 1 0 0 0 1
Figure 10, figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 2 , 1 8 1 0 0 0 1
significant reduction significant s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 no 0 10 1 0 0 0 1
the presence the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 . 1 8 1 0 0 0 1
antioligomerization activity antioligomerization a an ant anti BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 no 0 9 1 0 0 0 1
peptide. 53 peptide. p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 . 1 9 1 0 0 0 1
interesting effect interesting i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 10 1 0 0 0 1
trend, making trend, t tr tre tren BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 , 1 9 1 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 5 [] 2 10 1 0 0 0 1
with selected with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 .- 2 9 1 0 0 0 1
SY5Y differentiated sy5y S SY SY5 SY5Y BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 - 1 8 1 0 0 0 1
polyacrylamide gel polyacrylamide p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 . 1 9 1 0 0 0 1
treat the treat t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 5 - 1 7 1 0 0 0 1
polyacrylamide to polyacrylamide p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 no 0 8 1 0 0 0 1
aggregates formed aggregates a ag agg aggr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 9 1 0 0 0 1
related controls. related r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 9 1 0 0 0 1
been used been b be bee been BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 :. 2 9 1 0 0 0 1
Results show results R Re Res Resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 4 5 ,, 2 8 1 0 0 0 1
incubations at incubations i in inc incu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 8 1 0 0 0 1
migration pattern migration m mi mig migr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 (: 2 9 1 0 0 0 1
monomers, dimers, monomers, m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 ,,) 3 9 1 0 0 0 1
(HMW: >50 (hmw: ( (H (HM (HMW BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 (:)(). 6 8 1 0 0 0 1
Coincubation with coincubation C Co Coi Coin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 no 0 8 1 0 0 0 1
band signal, band b ba ban band BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 , 1 9 1 0 0 0 1
with Aβ with w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 3 1 0 0 0 1
■ CONCLUSION ■ ■ ■ ■ ■ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 8 no 0 10 0 0 0 0 1
In the in I In In In BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 8 ,,, 3 9 0 0 0 0 1
and biophysical and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 - 1 8 0 0 0 0 1
construct that construct c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 9 0 0 0 0 1
GPGKLVFF sequence gpgklvff G GP GPG GPGK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 8 - 1 8 0 0 0 0 1
ties of ties t ti tie ties BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 . 1 9 0 0 0 0 1
to prevent to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 -- 2 8 0 0 0 0 1
synergistic action synergistic s sy syn syne BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 no 0 9 0 0 0 0 1
that can that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 -. 2 9 0 0 0 0 1
interesting example interesting i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 10 0 0 0 0 1
the nontoxic the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 9 0 0 0 0 1
Figure 9. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 .- 2 9 1 0 0 0 1
after 24 after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 . 1 10 1 0 0 0 1
of 5 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 (.,,,). 7 9 1 0 0 0 1
concentrations of concentrations c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 (). 3 9 1 0 0 0 1
represent means represent r re rep repr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 . 1 8 1 0 0 0 1
Figure 10. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 10 .- 2 9 1 0 0 0 1
after 48 after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 . 1 9 1 0 0 0 1
incubated with incubated i in inc incu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 10 : 1 10 1 0 0 0 1
1:5. Coincubations 1:5. 1 1: 1:5 1:5. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 10 :. 2 8 1 0 0 0 1
performed as performed p pe per perf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 . 1 9 1 0 0 0 1
three independent three t th thr thre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 .*. 3 9 1 0 0 0 1
one-way ANOVA one-way o on one one- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 -.#.- 5 8 1 0 0 0 1
ANOVA + anova A AN ANO ANOV BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 10 . 1 2 1 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 5 11 no 0 10 1 1 0 0 0
pubs.acs.org/chemneuro pubs.acs.org/chemneuro pubs.acs.org/chemneuro p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 11 ../ 3 10 1 1 0 0 0
Research Article research R Re Res Rese BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 11 no 0 7 1 1 0 0 0
https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 5 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 5 11 ..,,- 5 8 0 1 0 0 0
1457 1457 1457 1 14 145 1457 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 5 11 no 0 10 0 1 0 0 0
into oligomeric/fibrillar into i in int into BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 /, 2 9 0 0 0 0 1
circular dichroism circular c ci cir circ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ., 2 9 0 0 0 0 1
combined with combined c co com comb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
cells, further cells, c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 , 1 10 0 0 0 0 1
of this of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ., 2 9 0 0 0 0 1
pharmaceutical functions pharmaceutical p ph pha phar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 , 1 9 0 0 0 0 1
findings suggest findings f fi fin find BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
vehicle for vehicle v ve veh vehi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
agents in agents a ag age agen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .,[] 4 9 0 0 0 0 1
peptide moieties, peptide p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 ,, 2 9 0 0 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 10 0 0 0 0 1
transport a transport t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ,, 2 9 0 0 0 0 1
opens up opens o op ope open BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
diagnosis and diagnosis d di dia diag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 8 0 0 0 0 1
calix[n]arene family calix[n]arene c ca cal cali BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 [] 2 9 0 0 0 0 1
differing in differing d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 , 1 10 0 0 0 0 1
the versatility the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 , 1 9 0 0 0 0 1
additional tool additional a ad add addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 - 1 8 0 0 0 0 1
calixarene conjugates calixarene c ca cal cali BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 . 1 8 0 0 0 0 1
■ EXPERIMENTAL ■ ■ ■ ■ ■ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 1 no 0 10 0 0 0 0 1
Materials and materials M Ma Mat Mate BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 1 . 1 7 0 0 0 0 1
analytical grade. analytical a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 .[] 3 8 0 0 0 0 1
peptide were peptide p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 1 no 0 8 0 0 0 0 1
reported below. reported r re rep repo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 .(). 4 8 0 0 0 0 1
MALDI-TOF spectra maldi-tof M MA MAL MALD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 1 -/ 2 8 0 0 0 0 1
instrument. The instrument. i in ins inst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 .-- 3 8 0 0 0 0 1
as a as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 . 1 9 0 0 0 0 1
(0.1 mg) (0.1 ( (0 (0. (0.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 (.)::.// 8 9 0 0 0 0 1
TFA. Sinapinic tfa. T TF TFA TFA. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 1 .()- 4 9 0 0 0 0 1
4-8 mg/vial 4-8 4 4- 4-8 4-8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 -/. 3 9 0 0 0 0 1
1 mL 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 1 .,. 3 9 0 0 0 0 1
were used were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 no 0 7 0 0 0 0 1
spectrometer. The spectrometer. s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 .-- 3 8 0 0 0 0 1
bradikynin, angiotensin bradikynin, b br bra brad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 1 ,,-,(-), 8 9 0 0 0 0 1
ACTH (Clip acth A AC ACT ACTH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 1 (-),(-), 8 8 0 0 0 0 1
cover a cover c co cov cove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 -. 2 4 0 0 0 0 1
1 H 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 1 (.),(.), 8 7 0 0 0 0 1
spectra were spectra s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 . 1 8 0 0 0 0 1
Chemical shifts chemical C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 1 ()(), 5 8 0 0 0 0 1
referenced to referenced r re ref refe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 1 ;() 3 9 0 0 0 0 1
are given are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 . 1 2 0 0 0 0 1
Synthesis of synthesis S Sy Syn Synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 1 (). 3 8 0 0 0 0 1
the microwave the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 no 0 9 0 0 0 0 1
Liberty Peptide liberty L Li Lib Libe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 1 (). 3 9 0 0 0 0 1
carried out carried c ca car carr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 (./) 4 8 0 0 0 0 1
using the using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 .- 2 8 0 0 0 0 1
introduced according introduced i in int intr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 // 2 7 0 0 0 0 1
activation methods. activation a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 .- 2 9 0 0 0 0 1
excess of excess e ex exc exce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 . 1 9 0 0 0 0 1
was achieved was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 . 1 8 0 0 0 0 1
following instrumental following f fo fol foll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 : 1 9 0 0 0 0 1
microwave power microwave m mi mic micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 ,, 2 8 0 0 0 0 1
300 s. 300 3 30 300 300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 1 . 1 9 0 0 0 0 1
were: microwave were: w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 :,, 3 7 0 0 0 0 1
deprotection time deprotection d de dep depr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 1 . 1 8 0 0 0 0 1
resin using resin r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 //(:.:.//). 11 9 0 0 0 0 1
peptides were peptides p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 1 no 0 10 0 0 0 0 1
ether. The ether. e et eth ethe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 .() 3 9 0 0 0 0 1
preparative reversed-phase preparative p pr pre prep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 1 -- 2 7 0 0 0 0 1
chromatography system chromatography c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 - 1 8 0 0 0 0 1
diode array diode d di dio diod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 1 . 1 9 0 0 0 0 1
C18 250 c18 C C1 C18 C18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 .(,) 4 8 0 0 0 0 1
used. The used. u us use used BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 ./ 2 9 0 0 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 : 1 9 0 0 0 0 1
solvent A solvent s so sol solv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 (.) 3 9 0 0 0 0 1
gradient from gradient g gr gra grad BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 (.) 3 9 0 0 0 0 1
min isocratic min m mi min min BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 6 4 . 1 9 0 0 0 0 1
product were product p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 . 1 8 0 0 0 0 1
confirmed by confirmed c co con conf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 -.:.; 5 7 0 0 0 0 1
observed: [M observed: o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 :[].;[].. 9 7 0 0 0 0 1
Synthesis of synthesis S Sy Syn Synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 ,,,----,,-- 11 8 0 0 0 0 1
28-(2-ethoxycarbonylmethoxy)-calix[4]arene (2). 28-(2-ethoxycarbonylmethoxy)-calix[4]arene 2 28 28- 28-( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 -(-)-[](). 10 8 0 0 0 0 1
(200 mg, (200 ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 (,.) 4 8 0 0 0 0 1
CH 2 ch C CH CH CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 (),--(.,.) 10 9 0 0 0 0 1
added. The added. a ad add adde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ., 2 9 0 0 0 0 1
solution (50 solution s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ()(). 5 8 0 0 0 0 1
phase was phase p ph pha phas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 () 2 8 0 0 0 0 1
(50 mL (50 ( (5 (50 (50 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 ()., 4 8 0 0 0 0 1
residue was residue r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 8 0 0 0 0 1
pure compound pure p pu pur pure BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 (,).(,):. 9 8 0 0 0 0 1
(t, 3H, (t, ( (t (t, (t, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 (,,.,),.(,,., 13 9 0 0 0 0 1
CH 3 ch C CH CH CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 ),.(,,.,),.,.,(,, 17 9 0 0 0 0 1
Boc CH boc B Bo Boc Boc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 ),.(,,),.(,,., 14 9 0 0 0 0 1
propyl CH propyl p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 ),..(,,., 9 8 0 0 0 0 1
ArCH 2 arch A Ar ArC ArCH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 ),..(,,., 9 7 0 0 0 0 1
ArCH 2 arch A Ar ArC ArCH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 ),.(,,.,),.(,, 14 9 0 0 0 0 1
= 7.4 = = = = = BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 4 .,),.(,,.,),. 13 9 0 0 0 0 1
(s, 2H, (s, ( (s (s, (s, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 (,,),.(,,),.(,,., 17 9 0 0 0 0 1
× ArH), × × × × × BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 4 ),.(,,.,),.(,,). 16 8 0 0 0 0 1
Synthesis of synthesis S Sy Syn Synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 ,,,----,,-- 11 8 0 0 0 0 1
28-(carbomethoxy)-calix[4]arene (3). 28-(carbomethoxy)-calix[4]arene 2 28 28- 28-( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 -()-[]().(,. 12 8 0 0 0 0 1
mmol) was mmol) m mm mmo mmol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 )()( 4 8 0 0 0 0 1
mL) and ml) m mL mL) mL) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 )(,.). 6 7 0 0 0 0 1
refluxed and refluxed r re ref refl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 . 1 8 0 0 0 0 1
HCl. The hcl. H HC HCl HCl. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 ., 2 9 0 0 0 0 1
was dried was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 8 0 0 0 0 1
(95.37 mg, (95.37 ( (9 (95 (95. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 (.,).(,):.(,,. 14 8 0 0 0 0 1
Hz, propyl hz, H Hz Hz, Hz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 ,),.(,,.,),.,., 15 10 0 0 0 0 1
(s, 18H (s, ( (s (s, (s, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 (,,),.(,,., 11 8 0 0 0 0 1
CH 2 ch C CH CH CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 ),..(,,., 9 8 0 0 0 0 1
ArCH 2 arch A Ar ArC ArCH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 ),..(,,., 9 7 0 0 0 0 1
ArCH 2 arch A Ar ArC ArCH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 ),.(,,.,),.(,, 14 9 0 0 0 0 1
= 7.4 = = = = = BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 4 .,),.(,,),.(,, 14 8 0 0 0 0 1
ArH), 7.08 arh), A Ar ArH ArH) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 ),.(,,). 8 3 0 0 0 0 1
Synthesis of synthesis S Sy Syn Synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 ---[]--- 8 7 0 0 0 0 1
gate (4) gate g ga gat gate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ()--[]- 7 8 0 0 0 0 1
Conjugate (5). conjugate C Co Con Conj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 ().(.) 6 8 0 0 0 0 1
dissolved in dissolved d di dis diss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ,(.,.) 6 8 0 0 0 0 1
DIPEA (10.5 dipea D DI DIP DIPE BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 (.,.). 6 8 0 0 0 0 1
for 2 for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ,()(., 6 8 0 0 0 0 1
0.020 mmol) 0.020 0 0. 0.0 0.02 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 .)(.,.). 8 8 0 0 0 0 1
After stirring after A Af Aft Afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 , 1 9 0 0 0 0 1
under vacuum, under u un und unde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ,, 2 8 0 0 0 0 1
with diethyl with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 .. 2 8 0 0 0 0 1
dried in dried d dr dri drie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 .(,.,) 6 8 0 0 0 0 1
was obtained was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 (/,:/). 7 8 0 0 0 0 1
Dde protecting dde D Dd Dde Dde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 no 0 8 0 0 0 0 1
with 2% with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 (),,,. 6 8 0 0 0 0 1
removal of removal r re rem remo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ,() 3 8 0 0 0 0 1
added to added a ad add adde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ,. 2 8 0 0 0 0 1
stirred at stirred s st sti stir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 . 1 8 0 0 0 0 1
vacuum, and vacuum, v va vac vacu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 , 1 8 0 0 0 0 1
centrifugation, to centrifugation, c ce cen cent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 ,(., 4 9 0 0 0 0 1
95% yield). 95% 9 95 95% 95% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 ).- 3 8 0 0 0 0 1
spectrometry. Calculated spectrometry. s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 .:.; 4 9 0 0 0 0 1
observed: 1536.0288 observed: o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 :.();.(). 9 8 0 0 0 0 1
(CDCl 3 (cdcl ( (C (CD (CDC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 (/:/,).(,,.,), 14 9 0 0 0 0 1
0.80 (d, 0.80 0 0. 0.8 0.80 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 .(,,.,),.(,,.,), 16 9 0 0 0 0 1
0.88 (d, 0.88 0 0. 0.8 0.88 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 .(,,.,),.(,,., 14 9 0 0 0 0 1
propyl), 0.96 propyl), p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 ),.(,,.,),.(,,. 15 9 0 0 0 0 1
Hz, CH hz, H Hz Hz, Hz, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 ,),.-.(,,),.-. 14 8 0 0 0 0 1
(overlapped, 10H, (overlapped, ( (o (ov (ove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 (,,,,),.-. 10 8 0 0 0 0 1
(m, 1H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 (,,.,),.-.(,,),. 16 8 0 0 0 0 1
2.24 (m, 2.24 2 2. 2.2 2.24 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 .(,,),.(,,),.-.( 16 8 0 0 0 0 1
dd, 2H, dd, d dd dd, dd, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 ,,),.-.(,, 10 8 0 0 0 0 1
calixarene, and calixarene, c ca cal cali BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 ,),.-.(,,), 11 9 0 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 7 11 no 0 10 0 1 0 0 0
pubs.acs.org/chemneuro pubs.acs.org/chemneuro pubs.acs.org/chemneuro p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 11 ../ 3 10 0 1 0 0 0
Research Article research R Re Res Rese BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 7 11 no 0 7 0 1 0 0 0
https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 7 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 7 11 ..,,- 5 8 0 1 0 0 0
1458 1458 1458 1 14 145 1458 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 7 11 no 0 10 0 1 0 0 0
3.96 (d, 3.96 3 3. 3.9 3.96 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .(,.,,),.(,,).- 15 8 0 0 0 0 1
4.36 (m 4.36 4 4. 4.3 4.36 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .(,,),.-. 9 7 0 0 0 0 1
(overlapped, 13H, (overlapped, ( (o (ov (ove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 (,,,,, 6 7 0 0 0 0 1
ArCH 2 arch A Ar ArC ArCH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 ,,,),.(,, 9 9 0 0 0 0 1
2 × 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 0 ),.(,,),.(, 11 9 0 0 0 0 1
2H, ArNH 2h, 2 2H 2H, 2H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 ,),.(,,),.( 11 9 0 0 0 0 1
s, 2H, s, s s, s, s, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,,),.(,,),.- 12 8 0 0 0 0 1
7.37 (overlapped, 7.37 7 7. 7.3 7.37 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .(,,).(/: 9 8 0 0 0 0 1
v/v, 297 v/v, v v/ v/v v/v, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 /,):.,.(),.,.,.,.(),..,., 25 10 0 0 0 0 1
25.0 (d), 25.0 2 25 25. 25.0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .(),.,.,.,.,.,.,.,.,.(),., 26 10 0 0 0 0 1
54.6, 55.9, 54.6, 5 54 54. 54.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,.,.,.(),.,.(),.,.,., 24 9 0 0 0 0 1
127.7, 129.3, 127.7, 1 12 127 127. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,.,.,.(),.,.,.,.,. 21 9 0 0 0 0 1
(s), 169.3, (s), ( (s (s) (s), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 (),.,.,.,.,.,.,.,.(,). 22 9 0 0 0 0 1
Sample Preparation. sample S Sa Sam Samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 7 0 .(/) 4 8 0 0 0 0 1
sonicated for sonicated s so son soni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 . 1 8 0 0 0 0 1
stream of stream s st str stre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,, 2 8 0 0 0 0 1
under N under u un und unde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 (). 3 8 0 0 0 0 1
was again was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 - 1 8 0 0 0 0 1
then lyophilized then t th the then BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 0 0 0 0 1
presence of presence p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 3 0 0 0 0 1
Circular Dichroism circular C Ci Cir Circ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 8 0 0 0 0 1
a J-810 a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 7 0 -(,) 4 9 0 0 0 0 1
room temperature. room r ro roo room BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .() 3 8 0 0 0 0 1
monomer in monomer m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 (). 3 8 0 0 0 0 1
lyophilized samples lyophilized l ly lyo lyop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 no 0 8 0 0 0 0 1
then diluted then t th the then BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 8 0 0 0 0 1
mM NaCl mm m mM mM mM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 0 0 0 0 1
the mixture the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 (::). 5 9 0 0 0 0 1
path length path p pa pat path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 - 1 9 0 0 0 0 1
(190-260 nm) (190-260 ( (1 (19 (190 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 (-)/. 5 8 0 0 0 0 1
collected. The collected. c co col coll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 0 0 0 0 1
from the from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 8 0 0 0 0 1
triplicate. triplicate. triplicate. t tr tri trip BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 1 0 0 0 0 1
Thioflavin T thioflavin T Th Thi Thio BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 . 1 8 0 0 0 0 1
measured on measured m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 0 0 0 0 1
excitation and excitation e ex exc exci BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,. 2 9 0 0 0 0 1
and in and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 :: 2 9 0 0 0 0 1
was dissolved was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 (). 3 8 0 0 0 0 1
(to 150 (to ( (t (to (to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 () 2 8 0 0 0 0 1
pH 7.4 ph p pH pH pH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .. 2 9 0 0 0 0 1
were incubated were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -. 2 9 0 0 0 0 1
effects the effects e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 - 1 9 0 0 0 0 1
plastic film. plastic p pl pla plas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ., 2 9 0 0 0 0 1
10 s. 10 1 10 10 10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 .. 2 8 0 0 0 0 1
measurements were measurements m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 8 0 0 0 0 1
during sample during d du dur duri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 7 0 0 0 0 1
monomerized Aβ monomerized m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 . 1 8 0 0 0 0 1
experimental data experimental e ex exp expe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 : 1 7 0 0 0 0 1
= + = = = = = BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 4 no 0 10 0 0 0 0 1
+ + + + + + + BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 4 no 0 5 0 0 0 0 1
+ -- + + + + + BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 4 -- 2 4 0 0 0 0 1
F t f F F F F BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 4 no 0 4 0 0 0 0 1
F F f F F F F BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 4 no 0 2 0 0 0 0 1
F F f F F F F BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 4 no 0 2 0 0 0 0 1
nt nt nt n nt nt nt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 no 0 3 0 0 0 0 1
( ) ( ( ( ( ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 4 () 2 4 0 0 0 0 1
1 e 1 1 1 1 1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 4 no 0 10 0 0 0 0 1
0 0 0 0 0 0 0 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 4 no 0 10 0 0 0 0 1
max max max m ma max max BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 7 4 no 0 10 0 0 0 0 1
/ / / / / / / BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 4 / 1 5 0 0 0 0 1
1/2 1/2 1/2 1 1/ 1/2 1/2 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 / 1 10 0 0 0 0 1
where F where w wh whe wher BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 no 0 9 0 0 0 0 1
increment of increment i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 ;/ 2 8 0 0 0 0 1
constant, and constant, c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 ,/ 2 9 0 0 0 0 1
is 50% is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 . 1 10 0 0 0 0 1
time axis time t ti tim time BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 no 0 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 ; 1 9 0 0 0 0 1
fitted parameters fitted f fi fit fitt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 :/-. 4 9 0 0 0 0 1
The kinetic the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 () 2 8 0 0 0 0 1
independent experiments. independent i in ind inde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 . 1 3 0 0 0 0 1
Dynamic Light dynamic D Dy Dyn Dyna BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 () 2 7 0 0 0 0 1
Scattering (ELS). scattering S Sc Sca Scat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 (). 3 8 0 0 0 0 1
a ZetaSizer a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 7 4 (), 3 8 0 0 0 0 1
633 nm 633 6 63 633 633 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 4 . 1 9 0 0 0 0 1
size of size s si siz size BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 ,, 2 8 0 0 0 0 1
determined on determined d de det dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 no 0 9 0 0 0 0 1
as CD as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 .. 2 8 0 0 0 0 1
Atomic Force atomic A At Ato Atom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 . 1 8 0 0 0 0 1
PSIAXE-150 system, psiaxe-150 P PS PSI PSIA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 -,. 3 9 0 0 0 0 1
measurements were measurements m me mea meas BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 no 0 8 0 0 0 0 1
doped tip doped d do dop dope BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 (.). 4 9 0 0 0 0 1
New cantilevers new N Ne New New BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 .: 2 8 0 0 0 0 1
thickness 4 thickness t th thi thic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ,,./ 4 9 0 0 0 0 1
m, and m, m m, m, m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ,. 2 9 0 0 0 0 1
An aliquot an A An An An BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 8 6 no 0 8 0 0 0 0 1
precleaned silicon precleaned p pr pre prec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 . 1 9 0 0 0 0 1
representative investigation representative r re rep repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 , 1 9 0 0 0 0 1
substrates were substrates s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 -( 2 9 0 0 0 0 1
in literature). in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 6 )., 3 9 0 0 0 0 1
investigated and investigated i in inv inve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 . 1 8 0 0 0 0 1
Mass Spectrometry mass M Ma Mas Mass BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 . 1 8 0 0 0 0 1
in HFIP in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 6 (). 3 9 0 0 0 0 1
10 -4 10 1 10 10 10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 6 -(). 4 7 0 0 0 0 1
compound 5 compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 8 0 0 0 0 1
1.1 × 1.1 1 1. 1.1 1.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 .-./ 4 9 0 0 0 0 1
GPGKLVFF and gpgklvff G GP GPG GPGK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 /:, 3 8 0 0 0 0 1
solutions to solutions s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 [].-,[] 7 9 0 0 0 0 1
[GPGKLVFF] = [gpgklvff] [ [G [GP [GPG BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 [].--. 6 9 0 0 0 0 1
For proteolysis for F Fo For For BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 ,- 2 8 0 0 0 0 1
dissolved in dissolved d di dis diss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 -[].-, 6 9 0 0 0 0 1
appropriate volume appropriate a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 8 0 0 0 0 1
Aβ 42 aβ A Aβ Aβ Aβ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,/,/ 4 8 0 0 0 0 1
enzyme/substrate ratio enzyme/substrate e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 /:/. 4 9 0 0 0 0 1
°C, and °c, ° °C °C, °C, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 , 1 9 0 0 0 0 1
1 μL 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 8 6 ..- 3 8 0 0 0 0 1
MS Orbitrap ms M MS MS MS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 -(). 4 8 0 0 0 0 1
was introduced was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 8 0 0 0 0 1
fused silica fused f fu fus fuse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ./ 2 9 0 0 0 0 1
400-4000 were 400-4000 4 40 400 400- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 -,. 3 9 0 0 0 0 1
kV, capillary kv, k kV kV, kV, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ,;/-,- 6 8 0 0 0 0 1
RF level rf R RF RF RF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,,:. 4 9 0 0 0 0 1
spectra, recorded spectra, s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ,, 2 8 0 0 0 0 1
(Thermo Scientific) (thermo ( (T (Th (The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 (). 3 9 0 0 0 0 1
imported into imported i im imp impo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 -,(:// 6 9 0 0 0 0 1
www.mmass.org). Theoretical www.mmass.org). w ww www www. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ..)./,,, 8 9 0 0 0 0 1
adducts Aβ adducts a ad add addu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 //, 3 8 0 0 0 0 1
from in from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 / 1 9 0 0 0 0 1
assigned to assigned a as ass assi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 . 1 8 0 0 0 0 1
successfully, within successfully, s su suc succ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ,.,. 4 8 0 0 0 0 1
Cell Cultures cell C Ce Cel Cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 .(), 4 8 0 0 0 0 1
SH-SY5Y, was sh-sy5y, S SH SH- SH-S BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 -,-(,) 6 7 0 0 0 0 1
supplemented with supplemented s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ()(, 4 9 0 0 0 0 1
ThermoFisher), 100 thermofisher), T Th The Ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ),/(, 5 8 0 0 0 0 1
ThermoFisher), and thermofisher), T Th The Ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ),-,. 5 9 0 0 0 0 1
before experiments, before b be bef befo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ,- 2 9 0 0 0 0 1
DMEM-F12 with dmem-f12 D DM DME DMEM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 -. 2 8 0 0 0 0 1
was gradually was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 .-- 3 10 0 0 0 0 1
acid (RA) acid a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ()(),, 6 7 0 0 0 0 1
differentiation, and differentiation, d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ,- 2 8 0 0 0 0 1
days. Treatments days. d da day days BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 .,, 3 8 0 0 0 0 1
performed on performed p pe per perf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ., 2 9 0 0 0 0 1
were incubated were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 (./) 4 8 0 0 0 0 1
lysed with lysed l ly lys lyse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 , 1 8 0 0 0 0 1
plate reader plate p pl pla plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 . 1 6 0 0 0 0 1
Antioligomerization Assay. antioligomerization A An Ant Anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 . 1 8 0 0 0 0 1
previously described previously p pr pre prev BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 9 0 0 0 0 1
monomerization. An monomerization. m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 . 1 9 0 0 0 0 1
mM DMSO. mm m mM mM mM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 .-- 3 7 0 0 0 0 1
without Phenol without w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 9 0 0 0 0 1
at 4 at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 9 0 0 0 0 1
as previously as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 . 1 8 0 0 0 0 1
compound 5 compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 (, 2 7 0 0 0 0 1
GPGKLVFF), samples gpgklvff), G GP GPG GPGK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ),() 4 7 0 0 0 0 1
presence or presence p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 (/:,:). 7 9 0 0 0 0 1
After 48 after A Af Aft Afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 ,/ 2 8 0 0 0 0 1
differentiated SH-SY5Y differentiated d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 -. 2 9 0 0 0 0 1
Western Blot western W We Wes West BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 . 1 8 0 0 0 0 1
dissolved in dissolved d di dis diss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 -, 2 8 0 0 0 0 1
and two and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 8 0 0 0 0 1
prepared. From prepared. p pr pre prep BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ., 2 9 0 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 8 11 no 0 10 0 1 0 0 0
pubs.acs.org/chemneuro pubs.acs.org/chemneuro pubs.acs.org/chemneuro p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 11 ../ 3 10 0 1 0 0 0
Research Article research R Re Res Rese BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 8 11 no 0 7 0 1 0 0 0
https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 8 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 8 11 ..,,- 5 8 0 1 0 0 0
1459 1459 1459 1 14 145 1459 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 8 11 no 0 10 0 1 0 0 0
combining Aβ combining c co com comb BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ,, 2 8 0 0 0 0 1
with a with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 /:., 4 9 0 0 0 0 1
alone at alone a al alo alon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 , 1 10 0 0 0 0 1
to form to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ., 2 9 0 0 0 0 1
aggregates were aggregates a ag agg aggr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 . 1 9 0 0 0 0 1
μL of μl μ μL μL μL BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 - 1 9 0 0 0 0 1
(Bolt 4-12%, (bolt ( (B (Bo (Bol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (-,)---- 8 9 0 0 0 0 1
fonic acid fonic f fo fon foni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (). 3 9 0 0 0 0 1
membrane (0.2 membrane m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 (.,,) 5 8 0 0 0 0 1
transfer unit transfer t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 (). 3 9 0 0 0 0 1
blocked in blocked b bl blo bloc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 (-) 3 8 0 0 0 0 1
incubated at incubated i in inc incu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 -- 2 9 0 0 0 0 1
antibody against antibody a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 --(:)(). 8 9 0 0 0 0 1
secondary goat secondary s se sec seco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 - 1 8 0 0 0 0 1
(1:25 000) (1:25 ( (1 (1: (1:2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (:). 4 9 0 0 0 0 1
detected with detected d de det dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 (- 2 8 0 0 0 0 1
Biosciences, Lincoln, biosciences, B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,,). 4 3 0 0 0 0 1
■ ASSOCIATED ■ ■ ■ ■ ■ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 1 no 0 10 0 0 0 0 1
* sı * * * * * BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 1 * 1 10 0 0 0 0 1
The Supporting the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 1 no 0 10 0 0 0 0 1
https://pubs.acs.org/doi/10.1021/acschemneuro.1c00117. https://pubs.acs.org/doi/10.1021/acschemneuro.1c00117. https://pubs.acs.org/doi/10.1021/acschemneuro.1c00117. h ht htt http BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 9 1 ://..//./.. 11 9 0 0 0 0 1
Tables containing tables T Ta Tab Tabl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 9 1 no 0 8 0 0 0 0 1
structures and structures s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 ,,,, 4 8 0 0 0 0 1
ThT spectra, tht T Th ThT ThT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 1 ,; 2 8 0 0 0 0 1
analysis (PDF) analysis a an ana anal BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 () 2 2 0 0 0 0 1
■ AUTHOR ■ ■ ■ ■ ■ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 2 no 0 10 0 0 0 0 1
Corresponding Authors corresponding C Co Cor Corr BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 no 0 10 0 0 0 0 1
Giuseppe Pappalardo giuseppe G Gi Giu Gius BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 9 2 --, 3 9 0 0 0 0 1
95126 Catania, 95126 9 95 951 9512 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 2 ,;./---; 8 9 0 0 0 0 1
Email: giuseppe.pappalardo@cnr.it email: E Em Ema Emai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 2 :.@. 4 5 0 0 0 0 1
Grazia Maria grazia G Gr Gra Graz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 9 2 -- 2 8 0 0 0 0 1
Biomolecular Chemistry, biomolecular B Bi Bio Biom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 2 ,,;./ 5 10 0 0 0 0 1
0000-0003-4189-930X; Email: 0000-0003-4189-930x; 0 00 000 0000 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 2 ---;:.@.. 9 9 0 0 0 0 1
Authors Authors authors A Au Aut Auth BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 no 0 10 0 0 0 0 1
Rita Tosto rita R Ri Rit Rita BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 9 2 -, 2 9 0 0 0 0 1
University of university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 ,,;- 4 9 0 0 0 0 1
of Crystallography, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 ,, 2 6 0 0 0 0 1
Ausilia Baglieri ausilia A Au Aus Ausi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 2 --, 3 9 0 0 0 0 1
95126 Catania, 95126 9 95 951 9512 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 2 , 1 3 0 0 0 0 1
Salvatore Petralia salvatore S Sa Sal Salv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 9 2 -, 2 10 0 0 0 0 1
University of university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 ,,;./ 5 9 0 0 0 0 1
0000-0001-5692-1130 0000-0001-5692-1130 0000-0001-5692-1130 0 00 000 0000 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 2 --- 3 3 0 0 0 0 1
Tiziana Campagna tiziana T Ti Tiz Tizi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 2 --, 3 8 0 0 0 0 1
95126 Catania, 95126 9 95 951 9512 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 2 , 1 3 0 0 0 0 1
Giuseppe Di giuseppe G Gi Giu Gius BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 9 2 --, 3 9 0 0 0 0 1
95126 Catania, 95126 9 95 951 9512 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 2 , 1 3 0 0 0 0 1
Stefania Zimbone stefania S St Ste Stef BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 9 2 --, 3 9 0 0 0 0 1
Catania, Italy catania, C Ca Cat Cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 2 , 1 2 0 0 0 0 1
Maria Laura maria M Ma Mar Mari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 9 2 --, 3 9 0 0 0 0 1
95126 Catania, 95126 9 95 951 9512 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 2 , 1 3 0 0 0 0 1
Complete contact complete C Co Com Comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 : 1 7 0 0 0 0 1
https://pubs.acs.org/10.1021/acschemneuro.1c00117 https://pubs.acs.org/10.1021/acschemneuro.1c00117 https://pubs.acs.org/10.1021/acschemneuro.1c00117 h ht htt http BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 9 2 ://.././. 9 8 0 0 0 0 1
Author Contributions author A Au Aut Auth BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 no 0 10 0 0 0 0 1
G.P. designed g.p. G G. G.P G.P. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 3 ..,, 4 9 0 0 0 0 1
paper; G.M.L.C. paper; p pa pap pape BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 ;....- 6 9 0 0 0 0 1
arene synthesis, arene a ar are aren BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 ,-,- 4 10 0 0 0 0 1
ments; R.T. ments; m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 ;.. 3 9 0 0 0 0 1
measurements; A.B. measurements; m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 ;..,- 5 9 0 0 0 0 1
peptide conjugation, peptide p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 ,;.. 4 9 0 0 0 0 1
AFM measurements; afm A AF AFM AFM BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 3 ;..; 4 8 0 0 0 0 1
G.D.N. performed g.d.n. G G. G.D G.D. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 4 ...;..... 9 10 0 1 0 0 1
biological experiments. biological b bi bio biol BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 4 . 1 4 0 1 0 0 1
Notes Notes notes N No Not Note BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 4 no 0 10 0 1 0 0 1
The authors the T Th The The BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 4 . 1 10 0 0 0 0 1
■ ACKNOWLEDGMENTS ■ ■ ■ ■ ■ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 4 no 0 10 0 0 0 0 1
Authors thank authors A Au Aut Auth BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 4 - 1 8 0 0 0 0 1
dell'Istruzione e dell'istruzione d de del dell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 4 '- 2 8 0 0 0 0 1
pubblico N.11/2017 pubblico p pu pub pubb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 4 ./ 2 8 0 0 0 0 1
Operativo Sicilia operativo O Op Ope Oper BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 4 -"' 3 8 0 0 0 0 1
sistema della sistema s si sis sist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 4 -". 3 10 0 0 0 0 1
Project TE(A)CH project P Pr Pro Proj BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 4 (). 3 5 0 0 0 0 1
■ REFERENCES ■ ■ ■ ■ ■ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 5 no 0 10 0 0 0 0 1
(1) Tóth, (1) ( (1 (1) (1) BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),.,,.,,.()' 13 8 0 0 0 0 1
disease mortality disease d di dis dise BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 :. 2 9 0 0 0 0 1
Int. J. int. I In Int Int. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ..'.,-. 7 5 0 0 0 0 1
(2) Armstrong, (2) ( (2 (2) (2) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),..()'. 9 8 0 0 0 0 1
Folia Neuropathol. folia F Fo Fol Foli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 .,-. 4 4 0 0 0 0 1
(3) Hardy, (3) ( (3 (3) (3) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),.,,..() 10 8 0 0 0 0 1
Alzheimer's disease: alzheimer's A Al Alz Alzh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ': 2 7 0 0 0 0 1
therapeutics. Science therapeutics. t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 .,-. 4 4 0 0 0 0 1
(4) Stefani, (4) ( (4 (4) (4) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),.,,..() 10 8 0 0 0 0 1
aggregate toxicity: aggregate a ag agg aggr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 :, 2 8 0 0 0 0 1
diseases and diseases d di dis dise BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ....,-. 7 8 0 0 0 0 1
(5) Cheignon, (5) ( (5 (5) (5) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),.,,.,-,.,,., 15 8 0 0 0 0 1
Hureau, C., hureau, H Hu Hur Hure BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,.,,.() 7 9 0 0 0 0 1
Beta peptide beta B Be Bet Beta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 '..,-. 6 8 0 0 0 0 1
(6) Darling, (6) ( (6 (6) (6) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),..,,.() 10 8 0 0 0 0 1
amyloid-β oligomers amyloid-β a am amy amyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 -. 2 8 0 0 0 0 1
Neurosci. 43, neurosci. N Ne Neu Neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 .,-. 4 3 0 0 0 0 1
(7) Ciudad, (7) ( (7 (7) (7) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),.,,.,,.,,.,,. 16 9 0 0 0 0 1
S., Do, s., S S. S., S., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 .,,.,,.,,.,,.,,., 17 8 0 0 0 0 1
Cianferani, S., cianferani, C Ci Cia Cian BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,.,,.,,.,,.,, 13 9 0 0 0 0 1
N. (2020) n. N N. N. N. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 .()(-) 6 8 0 0 0 0 1
conductivity pores conductivity c co con cond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 .. 2 8 0 0 0 0 1
Commun. 11, commun. C Co Com Comm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 .,-. 4 3 0 0 0 0 1
(8) Cox, (8) ( (8 (8) (8) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),..,,.,,.,,..,,.., 20 9 0 0 0 0 1
Joel, J. joel, J Jo Joe Joel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,..,,..,,.,,..,,.., 19 9 0 0 0 0 1
Ramamoorthy, A. ramamoorthy, R Ra Ram Rama BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,.()- 5 7 0 0 0 0 1
Membrane Interface membrane M Me Mem Memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 -. 2 8 0 0 0 0 1
59, 2249-2258. 59, 5 59 59, 59, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 ,-. 3 2 0 0 0 0 1
(9) Sahoo, (9) ( (9 (9) (9) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),..,,..,,.()- 15 8 0 0 0 0 1
resolution probing resolution r re res reso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 - 1 9 0 0 0 0 1
Alzheimer's disease. alzheimer's A Al Alz Alzh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 '...,-. 7 6 0 0 0 0 1
(10) Brender, (10) ( (1 (10 (10) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),..,,.,,..,,., 16 9 0 0 0 0 1
Bera, S., bera, B Be Ber Bera BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,.,,.,,..,,.,,.,,., 19 9 0 0 0 0 1
Ramamoorthy, A. ramamoorthy, R Ra Ram Rama BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,.()- 5 8 0 0 0 0 1
amyloid beta amyloid a am amy amyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 ...,- 5 8 0 0 0 0 1
4486. 4486. 4486. 4 44 448 4486 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 . 1 0 0 0 0 0 1
(11) Wang, (11) ( (1 (11 (11) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),.,,.,,.,,.() 15 8 0 0 0 0 1
amyloid-β; aggregation amyloid-β; a am amy amyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 -;'...., 8 9 0 0 0 0 1
1223-1243. 1223-1243. 1223-1243. 1 12 122 1223 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 -. 2 1 0 0 0 0 1
(12) Giuffrida, (12) ( (1 (12 (12) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),..,,.,,.,,.,, 16 9 0 0 0 0 1
P., Bruno, p., P P. P., P., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 .,,.,,.,,.,,.,, 15 9 0 0 0 0 1
A., Garozzo, a., A A. A., A., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 .,,.,,.,,.,,.()- 16 9 0 0 0 0 1
Amyloid monomers amyloid A Am Amy Amyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ...,- 5 8 0 0 0 0 1
10587. 10587. 10587. 1 10 105 1058 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 . 1 0 0 0 0 0 1
(13) Doig, (13) ( (1 (13 (13) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),..,,.() 10 8 0 0 0 0 1
beta-amyloid aggregation. beta-amyloid b be bet beta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 -.....,-. 9 8 0 0 0 0 1
(14) Jokar, (14) ( (1 (14 (14) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),.,,.,,.,,.,, 15 9 0 0 0 0 1
M., Beiki, m., M M. M., M., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 .,,.,,.() 9 9 0 0 0 0 1
applications of applications a ap app appl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 5 - 1 8 0 0 0 0 1
Alzheimer's disease alzheimer's A Al Alz Alzh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 '...,-. 7 7 0 0 0 0 1
(15) Sinopoli, (15) ( (1 (15 (15) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),.,,.,,..,,.., 16 9 0 0 0 0 1
Leone, M., leone, L Le Leo Leon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,.,,.,,.,,.,,.,, 16 10 0 0 0 0 1
M., Copani, m., M M. M., M., BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 .,,.,,.,,.()-- 14 9 0 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 10 11 no 0 10 0 1 0 0 0
pubs.acs.org/chemneuro pubs.acs.org/chemneuro pubs.acs.org/chemneuro p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 11 ../ 3 10 0 1 0 0 0
Research Article research R Re Res Rese BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 10 11 no 0 7 0 1 0 0 0
https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 10 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 10 11 ..,,- 5 8 0 1 0 0 0
1460 1460 1460 1 14 146 1460 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 10 11 no 0 10 0 1 0 0 0
Th: A th: T Th Th: Th: BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 :- 2 9 0 0 0 0 1
amyloid-β Oligomer amyloid-β a am amy amyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 -., 3 8 0 0 0 0 1
1541-1549. 1541-1549. 1541-1549. 1 15 154 1541 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 -. 2 1 0 0 0 0 1
(16) Di (16) ( (1 (16 (16) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.,,.,,.,,.., 15 8 0 0 0 0 1
Giuffrida, M. giuffrida, G Gi Giu Giuf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..,,.,,.() 11 9 0 0 0 0 1
therapeutics of therapeutics t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ':- 3 9 0 0 0 0 1
protective role protective p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -. 2 9 0 0 0 0 1
Pept. Sci. pept. P Pe Pep Pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ..,.. 5 3 0 0 0 0 1
(17) Savelieff, (17) ( (1 (17 (17) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),..,,.,,...,,.., 18 10 0 0 0 0 1
Lee, H. lee, L Le Lee Lee, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ,..,,.,,..() 12 9 0 0 0 0 1
that displays that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 --- 3 9 0 0 0 0 1
implicated in implicated i im imp impl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 '...,-. 7 8 0 0 0 0 1
(18) Korshavn, (18) ( (1 (18 (18) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),..,,.,,..,,.,,., 19 9 0 0 0 0 1
Bhunia, A., bhunia, B Bh Bhu Bhun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,.,,..() 14 9 0 0 0 0 1
Reactivity of reactivity R Re Rea Reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 --- 3 8 0 0 0 0 1
glycosylated polyphenols glycosylated g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ... 3 9 0 0 0 0 1
(17842), 15. (17842), ( (1 (17 (178 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 (),. 4 1 0 0 0 0 1
(19) Hindo, (19) ( (1 (19 (19) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),..,,..,,..,,., 17 8 0 0 0 0 1
Vivekanandan, S., vivekanandan, V Vi Viv Vive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,..() 11 8 0 0 0 0 1
molecule modulators molecule m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -.... 5 9 0 0 0 0 1
Soc. 131, soc. S So Soc Soc. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,-. 4 3 0 0 0 0 1
(20) Hsu, (20) ( (2 (20 (20) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.,,.,,.() 12 8 0 0 0 0 1
formation of formation f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .,-. 4 8 0 0 0 0 1
(21) Pederzoli, (21) ( (2 (21 (21) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.,,.,,.,,.,,.., 18 9 0 0 0 0 1
Grabrucker, S., grabrucker, G Gr Gra Grab BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.,,.,,.,,.,, 16 10 0 0 0 0 1
M., Vandelli, m., M M. M., M., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,,..,,.,,..() 14 8 0 0 0 0 1
Nanomedicine against nanomedicine N Na Nan Nano BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 - 1 8 0 0 0 0 1
delivery: In delivery: d de del deli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 :.,-. 5 7 0 0 0 0 1
(22) Tjernberg, (22) ( (2 (22 (22) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),..,,.,,.,,., 15 9 0 0 0 0 1
Karlstrom, A. karlstrom, K Ka Kar Karl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..,,.,,.,,.() 14 9 0 0 0 0 1
Arrest of arrest A Ar Arr Arre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 -.. 3 9 0 0 0 0 1
Biol. Chem. biol. B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ..,-. 5 3 0 0 0 0 1
(23) Ghanta, (23) ( (2 (23 (23) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.,,.-.,,..,,.. 17 9 0 0 0 0 1
(1996) A (1996) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ()-.. 5 10 0 0 0 0 1
Biol. Chem. biol. B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ..,-. 5 4 0 0 0 0 1
(24) Lowe, (24) ( (2 (24 (24) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),..,,.,,..,,.. 16 9 0 0 0 0 1
(2001) Structure (2001) ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ()-- 4 9 0 0 0 0 1
toxicity containing toxicity t to tox toxi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ., 2 9 0 0 0 0 1
7882-7889. 7882-7889. 7882-7889. 7 78 788 7882 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -. 2 1 0 0 0 0 1
(25) Zhang, (25) ( (2 (25 (25) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.,,.,,.,,.,,.()- 19 9 0 0 0 0 1
LVFFARK-NH 2 lvffark-nh L LV LVF LVFF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 -- 2 9 0 0 0 0 1
enhanced performance enhanced e en enh enha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 - 1 9 0 0 0 0 1
and cytotoxicity. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ...,-. 6 6 0 0 0 0 1
(26) Chafekar, (26) ( (2 (26 (26) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),..,,.,,.,,..,,., 19 9 0 0 0 0 1
Lashuel, H. lashuel, L La Las Lash BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..,,.,,.() 11 8 0 0 0 0 1
tetramers strongly tetramers t te tet tetr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 -. 2 9 0 0 0 0 1
ChemBioChem 8, chembiochem C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,-. 3 3 0 0 0 0 1
(27) Villari, (27) ( (2 (27 (27) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.,,.,,.,,.,,. 16 10 0 0 0 0 1
F., Lazzaro, f., F F. F., F., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,,.,,.,,..()- 14 8 0 0 0 0 1
loporphyrin-peptide conjugate loporphyrin-peptide l lo lop lopo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 -- 2 9 0 0 0 0 1
peptide fibrillation peptide p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .,-. 4 9 0 0 0 0 1
(28) Lazzaro, (28) ( (2 (28 (28) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.,,.,,.,,.,, 15 9 0 0 0 0 1
G., and g., G G. G., G., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .,,...() 8 9 0 0 0 0 1
with multivariate with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 : 1 10 0 0 0 0 1
candidate for candidate c ca can cand BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 '-. 3 9 0 0 0 0 1
Anal. Bioanal. anal. A An Ana Anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ...,-. 6 5 0 0 0 0 1
(29) Zhang, (29) ( (2 (29 (29) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.,,..,,..,,.() 17 9 0 0 0 0 1
Multiple-peptide conjugates multiple-peptide M Mu Mul Mult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 -- 2 8 0 0 0 0 1
Alzheimer's disease. alzheimer's A Al Alz Alzh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 '..,-. 6 7 0 0 0 0 1
(30) Ryan, (30) ( (3 (30 (30) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.,,.,,.,,..,,., 18 9 0 0 0 0 1
Davey, A., davey, D Da Dav Dave BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,..,,.,,.() 14 8 0 0 0 0 1
Peptides, peptidomimetics, peptides, P Pe Pep Pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,,- 3 9 0 0 0 0 1
amyloidogenic aggregation amyloidogenic a am amy amyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 '. 2 9 0 0 0 0 1
Chem. Neurosci. chem. C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ..,-. 5 4 0 0 0 0 1
(31) Tesauro, (31) ( (3 (31 (31) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.,,.,,.,,.,,., 17 9 0 0 0 0 1
Ronga, L., ronga, R Ro Ron Rong BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.,,.()-- 9 9 0 0 0 0 1
in biotechnological in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 0 :. 2 9 0 0 0 0 1
Molecules 24, molecules M Mo Mol Mole BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ,. 2 2 0 0 0 0 1
(32) Neri, (32) ( (3 (32 (32) BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.,,..,,.-.() 15 9 0 0 0 0 1
Beyond, Springer beyond, B Be Bey Beyo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ,,. 3 7 0 0 0 0 1
(33) Pan, (33) ( (3 (33 (33) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.-.,,.-.,,.-.() 18 8 0 0 0 0 1
application of application a ap app appl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 :..., 5 10 0 0 0 0 1
Int. Ed. int. I In Int Int. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ..,-. 5 3 0 0 0 0 1
(34) Viola, (34) ( (3 (34 (34) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.,,...,,.,,.,,.., 20 10 0 0 0 0 1
and Geraci, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,.() 4 9 0 0 0 0 1
proliferation by proliferation p pr pro prol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 [] 2 9 0 0 0 0 1
and ureido and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ...,-. 6 7 0 0 0 0 1
(35) Consoli, (35) ( (3 (35 (35) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),...,,.,,.,,.., 17 9 0 0 0 0 1
Geraci, C., geraci, G Ge Ger Gera BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.,,.,,.(), 11 9 0 0 0 0 1
antibacterial evaluation antibacterial a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 [] 2 9 0 0 0 0 1
alone and alone a al alo alon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .,- 3 8 0 0 0 0 1
164. 164. 164. 1 16 164 164. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 . 1 0 0 0 0 0 1
(36) Geraci, (36) ( (3 (36 (36) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.,,...,,.,,., 16 8 0 0 0 0 1
Palmigiano, A., palmigiano, P Pa Pal Palm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.,,.,,..,,. 12 8 0 0 0 0 1
(2013) First (2013) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 ()- 3 8 0 0 0 0 1
candidates by candidates c ca can cand BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 - 1 8 0 0 0 0 1
dominant PDTRP dominant d do dom domi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 : 1 8 0 0 0 0 1
biological evaluation. biological b bi bio biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ..,-. 5 7 0 0 0 0 1
(37) Consoli, (37) ( (3 (37 (37) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),...,,.,,.,,.,, 17 9 0 0 0 0 1
M., and m., M M. M., M., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .,,.() 6 8 0 0 0 0 1
fluorescent folate-calix[4]arene fluorescent f fl flu fluo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 -[]: 4 9 0 0 0 0 1
and intracellular and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ....,-. 7 9 0 0 0 0 1
(38) Granata, (38) ( (3 (38 (38) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.,,.,,.,,.,,., 17 9 0 0 0 0 1
Cordaro, M., cordaro, C Co Cor Cord BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.,,..,,.,,... 14 8 0 0 0 0 1
(2017) Potential (2017) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 ()[] 4 9 0 0 0 0 1
curcumin delivery: curcumin c cu cur curc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 :,,- 4 8 0 0 0 0 1
inflammatory effect. inflammatory i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ..,-. 5 7 0 0 0 0 1
(39) Rodik, (39) ( (3 (39 (39) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),..,,..,,..,,., 17 9 0 0 0 0 1
Klymchenko, A. klymchenko, K Kl Kly Klym BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,..() 5 8 0 0 0 0 1
compact DNA compact c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .. 2 8 0 0 0 0 1
Chem. 39, chem. C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .,-. 4 2 0 0 0 0 1
(40) Zadmard, (40) ( (4 (40 (40) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.,,..() 10 8 0 0 0 0 1
recognition by recognition r re rec reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ..,-. 5 7 0 0 0 0 1
(41) Alex, (41) ( (4 (41 (41) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),..,,..,,.,,., 16 8 0 0 0 0 1
Dorottya, H., dorottya, D Do Dor Doro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.,,.,,.,,..() 14 8 0 0 0 0 1
Calixarene-mediated assembly calixarene-mediated C Ca Cal Cali BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 -. 2 9 0 0 0 0 1
6, 238-247. 6, 6 6, 6, 6, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 ,-. 3 1 0 0 0 0 1
(42) Wang, (42) ( (4 (42 (42) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.,,.,,.,,.()- 16 7 0 0 0 0 1
sulfonatocalix[n]arenes inhibit sulfonatocalix[n]arenes s su sul sulf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 []- 3 9 0 0 0 0 1
reduce amyloid reduce r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ..-.,-. 7 7 0 0 0 0 1
(43) Xu, (43) ( (4 (43 (43) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.,,.,,.,,.,,..,,.. 21 9 0 0 0 0 1
(2019) Heteromultivalent (2019) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 ()- 3 8 0 0 0 0 1
cyclodextrin and cyclodextrin c cy cyc cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 no 0 9 0 0 0 0 1
fibrillation. Nat. fibrillation. f fi fib fibr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ...,-. 6 4 0 0 0 0 1
(44) Geraci, (44) ( (4 (44 (44) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.,,...,,.,,., 16 8 0 0 0 0 1
Pappalardo, M., pappalardo, P Pa Pap Papp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.,,.()[] 9 8 0 0 0 0 1
with four with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 : 1 9 0 0 0 0 1
Synthesis, characterization, synthesis, S Sy Syn Synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ,,. 3 9 0 0 0 0 1
Bioconjugate Chem. bioconjugate B Bi Bio Bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .,-. 4 4 0 0 0 0 1
(45) Collins, (45) ( (4 (45 (45) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),..,,..(): 12 9 0 0 0 0 1
a versatile a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 10 5 ....,-. 7 9 0 0 0 0 1
(46) Hilbich, (46) ( (4 (46 (46) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.,-,.,,.,,.., 16 9 0 0 0 0 1
Beyreuther, K. beyreuther, B Be Bey Beyr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,.() 4 8 0 0 0 0 1
synthetic amyloid synthetic s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 '... 4 9 0 0 0 0 1
Biol. 218, biol. B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 .,-. 4 2 0 0 0 0 1
(47) Fasman, (47) ( (4 (47 (47) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),..() 7 9 0 0 0 0 1
analysis of analysis a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,,. 3 6 0 0 0 0 1
(48) Sreerama, (48) ( (4 (48 (48) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.,,..() 10 8 0 0 0 0 1
secondary structure secondary s se sec seco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 : 1 9 0 0 0 0 1
CONTIN, SELCON, contin, C CO CON CONT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,, 2 7 0 0 0 0 1
reference Set. reference r re ref refe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ...,-. 6 6 0 0 0 0 1
(49) Levine, (49) ( (4 (49 (49) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.() 6 8 0 0 0 0 1
Alzheimer's disease alzheimer's A Al Alz Alzh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 '-: 3 8 0 0 0 0 1
aggregation in aggregation a ag agg aggr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ..,-. 5 6 0 0 0 0 1
(50) Yu, (50) ( (5 (50 (50) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (),.,,..,,.,,..,,.., 20 9 0 0 0 0 1
Rutledge, P. rutledge, R Ru Rut Rutl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ,..,,..()- 10 8 0 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 11 11 no 0 10 0 1 0 0 0
pubs.acs.org/chemneuro pubs.acs.org/chemneuro pubs.acs.org/chemneuro p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 11 ../ 3 10 0 1 0 0 0
Research Article research R Re Res Rese BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 11 11 no 0 7 0 1 0 0 0
https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 11 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 11 11 ..,,- 5 8 0 1 0 0 0
1461 1461 1461 1 14 146 1461 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 11 11 no 0 10 0 1 0 0 0
macrocycle conjugates macrocycle m ma mac macr BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 - 1 9 0 0 0 0 1
in their in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 0 .,-. 4 8 0 0 0 0 1
(51) Lomakin, (51) ( (5 (51 (51) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 (),.,,..,,..() 14 7 0 0 0 0 1
Monitoring protein monitoring M Mo Mon Moni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 8 0 0 0 0 1
spectroscopy. Methods spectroscopy. s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ..,-. 5 5 0 0 0 0 1
(52) Morand, (52) ( (5 (52 (52) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 (),.,,.,,.() 12 8 0 0 0 0 1
peptides during peptides p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 .. 2 7 0 0 0 0 1
Spectrom. 7, spectrom. S Sp Spe Spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 .,-. 4 2 0 0 0 0 1
(53) De (53) ( (5 (53 (53) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 (),.,,..,,.,,.,, 16 9 0 0 0 0 1
B., Attanasio, b., B B. B., B., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 .,,.,,.,,.,,.() 15 9 0 0 0 0 1
Design and design D De Des Desi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 - 1 8 0 0 0 0 1
inhibitors of inhibitors i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 (-)...., 8 9 0 0 0 0 1
220-228. 220-228. 220-228. 2 22 220 220- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 -. 2 1 0 0 0 0 1
(54) Lambert, (54) ( (5 (54 (54) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 (),..,,..,,..,,., 17 8 0 0 0 0 1
Freed, R., freed, F Fr Fre Free BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 ,.,,.,,..,,.,,., 16 8 0 0 0 0 1
Viola, K. viola, V Vi Vio Viol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 ,..,,.,,.,,..,,..,, 19 9 0 0 0 0 1
W. L. w. W W. W. W. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ..(),- 6 9 0 0 0 0 1
potent central potent p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ....... 7 9 0 0 0 0 1
A. 95, a. A A. A. A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 .,-. 4 2 0 0 0 0 1
(55) Giuffrida, (55) ( (5 (55 (55) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 (),..,,..,,.,,., 16 8 0 0 0 0 1
Battaglia, G., battaglia, B Ba Bat Batt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,.,,.,,.,,.,,., 15 9 0 0 0 0 1
Chiechio, S., chiechio, C Ch Chi Chie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,.,,.,,.,,.,,.,, 16 10 0 0 0 0 1
E., Nicoletti, e., E E. E., E., BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 .,,.,,.()- 10 9 0 0 0 0 1
with type-1 with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 -- 2 8 0 0 0 0 1
supply to supply s su sup supp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ....(),. 8 7 0 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 11 11 no 0 10 0 1 0 0 0
pubs.acs.org/chemneuro pubs.acs.org/chemneuro pubs.acs.org/chemneuro p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 11 ../ 3 10 0 1 0 0 0
Research Article research R Re Res Rese BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 11 11 no 0 7 0 1 0 0 0
https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 https://doi.org/10.1021/acschemneuro.1c00117 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 11 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 11 11 ..,,- 5 8 0 1 0 0 0
1462 1462 1462 1 14 146 1462 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 11 11 no 0 10 0 1 0 0 0

